EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Based Screening of Antiviral Candidates Against Infectious Spleen and Kidney Necrosis Virus (ISKNV) Using Molecular Docking and In Vitro Evaluation

Eun-Jin Baek iD, Hyun-Deok Choi, Ye-Jin Jeong, Kwang-Il Kim iD

Biomolecules · 2026

DOI: 10.3390/biom16071022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Eun-Jin Baek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, Iridoviridae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infectious spleen and kidney necrosis virus (ISKNV) causes systemic infections and high mortality in various freshwater and marine fish species, posing a serious threat to aquaculture and ornamental fish industries. In this study, 72 antiviral compounds were screened against five ISKNV target proteins, DNA polymerase, transcription elongation factor (TFIIS), adenosine triphosphatase (ATPase), ankyrin repeat-containing protein, and major capsid protein (MCP) using molecular docking, followed by in vitro evaluation in dwarf gourami fin (DGF) cells. Fludarabine, liquiritin, and lycorine consistently ranked among the top 20 compounds across all five targets and were selected for further evaluation. Fludarabine and lycorine strongly inhibited MCP, ATPase, and DNA polymerase expression with inhibition rates exceeding 85%. Infectious viral titers were reduced by approximately 39- and 81-fold in the fludarabine- and lycorine-treated groups, respectively, compared with those in the ISKNV-infected control group. Time-course analysis revealed that both compounds suppressed extracellular viral release and delayed the progression of cytopathic effects. These results suggest that multi-target docking combined with in vitro evaluation may be a useful strategy for prioritizing antiviral candidates against ISKNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMolecular Docking SimulationIridoviridaeAnimalsCell LineFish DiseasesDrug Evaluation, PreclinicalPhenanthridinesAmaryllidaceae Alkaloids

Stichwörter der Autor:innen

antiviral activityin vitro evaluationinfectious spleen and kidney necrosis virusmolecular dockingstructure-based screening

Substanzen

Antiviral AgentslycorinePhenanthridinesAmaryllidaceae Alkaloids

Autor:innen und Institutionen

  • Department of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea.
  • Pathology Research Division, National Institute of Fisheries Science, Busan 46083, Republic of Korea.

ORCID-Profile: Eun-Jin Baek, Kwang-Il Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Baek, E. J., Choi, H. D., Jeong, Y. J., & Kim, K. I. (2026). Structure-Based Screening of Antiviral Candidates Against Infectious Spleen and Kidney Necrosis Virus (ISKNV) Using Molecular Docking and In Vitro Evaluation. Biomolecules. https://doi.org/10.3390/biom16071022

Vancouver

Baek EJ, Choi HD, Jeong YJ, Kim KI. Structure-Based Screening of Antiviral Candidates Against Infectious Spleen and Kidney Necrosis Virus (ISKNV) Using Molecular Docking and In Vitro Evaluation. Biomolecules. 2026. doi:10.3390/biom16071022

BibTeX
@article{Baek2026,
  author = {Baek, Eun-Jin and Choi, Hyun-Deok and Jeong, Ye-Jin and Kim, Kwang-Il},
  title = {Structure-Based Screening of Antiviral Candidates Against Infectious Spleen and Kidney Necrosis Virus (ISKNV) Using Molecular Docking and In Vitro Evaluation},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16071022}
}
Kostenlos starten →